Cephalexin
Product Images NDC 70934-840

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 70934-840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 840 20 Master Bottle Label Approval Rev A 03 21)

Label (70934 840 20 Master Bottle Label Approval Rev A 03 21)
Cephalexin Capsules, USP 250mg label for a 20 capsule bottle by Denton Pharma, Inc. DBA Northwind Pharmaceuticals. The label includes storage instructions at controlled room temperature (20° to 25°C) and safety warnings such as keeping out of reach of children and keeping the container tightly closed.*
FDA Label Image

Cephalexin-str (Cephalexin Str)

Cephalexin-str (Cephalexin Str)
Chemical structure of Cephalexin monohydrate showing its molecular composition and arrangement of atoms including a beta-lactam ring and side chains characteristic of this antibiotic.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.